cd29 antibody, anti-mouse Search Results


cd29  (Miltenyi Biotec)
94
Miltenyi Biotec cd29
Cd29, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd29/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
cd29 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
mouse/rat integrin beta 1/cd29 antibody  (Bio-Techne corporation)
96
Bio-Techne corporation mouse/rat integrin beta 1/cd29 antibody
Mouse/Rat Integrin Beta 1/Cd29 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse/rat integrin beta 1/cd29 antibody/product/Bio-Techne corporation
Average 96 stars, based on 1 article reviews
mouse/rat integrin beta 1/cd29 antibody - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
pe conjugated cd29 antibody  (Miltenyi Biotec)
94
Miltenyi Biotec pe conjugated cd29 antibody
Pe Conjugated Cd29 Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe conjugated cd29 antibody/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
pe conjugated cd29 antibody - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
cd29 apc  (Miltenyi Biotec)
94
Miltenyi Biotec cd29 apc
mADSCs characterization. ( a ) Representative photographs (5× magnification of an optical microscope, scale bar 500 µm) of mADSCs isolated from the subcutaneous adipose tissue of C57bl6 mice cultured in selection medium for 4 passages. ( b ) Accumulated cell number and ( c ) population doubling time (PTD) per hours of mADSCs from p3 to p11. Once 90% confluence was reached, cells were counted by an automated cell counter. Dots in line graphs represent the mean ± SEM values. ( d – i ) Representative histograms of the expression of CD44, <t>CD29,</t> CD90.2, Sca-1, CD45 and CD31 surface markers analyzed by FACS.
Cd29 Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd29 apc/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
cd29 apc - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
anti mouse cd29 itgb1 apc  (Miltenyi Biotec)
94
Miltenyi Biotec anti mouse cd29 itgb1 apc
mADSCs characterization. ( a ) Representative photographs (5× magnification of an optical microscope, scale bar 500 µm) of mADSCs isolated from the subcutaneous adipose tissue of C57bl6 mice cultured in selection medium for 4 passages. ( b ) Accumulated cell number and ( c ) population doubling time (PTD) per hours of mADSCs from p3 to p11. Once 90% confluence was reached, cells were counted by an automated cell counter. Dots in line graphs represent the mean ± SEM values. ( d – i ) Representative histograms of the expression of CD44, <t>CD29,</t> CD90.2, Sca-1, CD45 and CD31 surface markers analyzed by FACS.
Anti Mouse Cd29 Itgb1 Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse cd29 itgb1 apc/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
anti mouse cd29 itgb1 apc - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
fitc anti mouse cd29  (Miltenyi Biotec)
94
Miltenyi Biotec fitc anti mouse cd29
Mice were challenged with LPS via inhalation and sacrificed 4 hours later. In addition, neutrophils were depleted by antibody injection or mice were treated with simvastatin (2 µg/g bodyweight) 12 hours and one hour before or one hour after LPS exposure as indicated. A: Quantification of alveolar (top), interstitial (middle), and intravascular neutrophils (bottom) in mice treated as indicated. B: <t>FITC-dextran</t> clearance (top), albumin concentration (middle), and elastase activity (bottom) in BAL fluids in mice treated as indicated (n = 8–10 for each bar). Statistical significance was tested using one way ANOVA with Newman-Keuls Multiple Comparison test. * indicates significant difference compared to LPS-treated animals.
Fitc Anti Mouse Cd29, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fitc anti mouse cd29/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
fitc anti mouse cd29 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
supplier cd29 pe hms1 1 130 102 994 miltenyi biotec  (Miltenyi Biotec)
94
Miltenyi Biotec supplier cd29 pe hms1 1 130 102 994 miltenyi biotec
Flow cytometry antibody panel used for characterization.
Supplier Cd29 Pe Hms1 1 130 102 994 Miltenyi Biotec, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/supplier cd29 pe hms1 1 130 102 994 miltenyi biotec/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
supplier cd29 pe hms1 1 130 102 994 miltenyi biotec - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
cd29 pe vio770  (Miltenyi Biotec)
94
Miltenyi Biotec cd29 pe vio770
Flow cytometry antibody panel used for characterization.
Cd29 Pe Vio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd29 pe vio770/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
cd29 pe vio770 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
apc vio770 cd29  (Miltenyi Biotec)
94
Miltenyi Biotec apc vio770 cd29
(A) MSCs (Cyagen) used in this study expressed <t>CD29,</t> CD44, and Sca-1 while remaining negative for CD31 and CD45 in at least two late passage numbers.
Apc Vio770 Cd29, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/apc vio770 cd29/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
apc vio770 cd29 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
mouse-antihuman cd29 antibody β 1 integrin  (Biogenex)
90
Biogenex mouse-antihuman cd29 antibody β 1 integrin
(A) MSCs (Cyagen) used in this study expressed <t>CD29,</t> CD44, and Sca-1 while remaining negative for CD31 and CD45 in at least two late passage numbers.
Mouse Antihuman Cd29 Antibody β 1 Integrin, supplied by Biogenex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse-antihuman cd29 antibody β 1 integrin/product/Biogenex
Average 90 stars, based on 1 article reviews
mouse-antihuman cd29 antibody β 1 integrin - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
antihuman cd29 (beta-1 integrin) mouse monoclonal antibody  (Novocastra)
90
Novocastra antihuman cd29 (beta-1 integrin) mouse monoclonal antibody
Comparison of MAPK expression of bone marrow by abatacept.
Antihuman Cd29 (Beta 1 Integrin) Mouse Monoclonal Antibody, supplied by Novocastra, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antihuman cd29 (beta-1 integrin) mouse monoclonal antibody/product/Novocastra
Average 90 stars, based on 1 article reviews
antihuman cd29 (beta-1 integrin) mouse monoclonal antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
pe-cy5 mouse anti-human cd29 antibody  (GraphPad Software Inc)
90
GraphPad Software Inc pe-cy5 mouse anti-human cd29 antibody
Comparison of MAPK expression of bone marrow by abatacept.
Pe Cy5 Mouse Anti Human Cd29 Antibody, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe-cy5 mouse anti-human cd29 antibody/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
pe-cy5 mouse anti-human cd29 antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


mADSCs characterization. ( a ) Representative photographs (5× magnification of an optical microscope, scale bar 500 µm) of mADSCs isolated from the subcutaneous adipose tissue of C57bl6 mice cultured in selection medium for 4 passages. ( b ) Accumulated cell number and ( c ) population doubling time (PTD) per hours of mADSCs from p3 to p11. Once 90% confluence was reached, cells were counted by an automated cell counter. Dots in line graphs represent the mean ± SEM values. ( d – i ) Representative histograms of the expression of CD44, CD29, CD90.2, Sca-1, CD45 and CD31 surface markers analyzed by FACS.

Journal: Cells

Article Title: Methylglyoxal Impairs the Pro-Angiogenic Ability of Mouse Adipose-Derived Stem Cells (mADSCs) via a Senescence-Associated Mechanism

doi: 10.3390/cells12131741

Figure Lengend Snippet: mADSCs characterization. ( a ) Representative photographs (5× magnification of an optical microscope, scale bar 500 µm) of mADSCs isolated from the subcutaneous adipose tissue of C57bl6 mice cultured in selection medium for 4 passages. ( b ) Accumulated cell number and ( c ) population doubling time (PTD) per hours of mADSCs from p3 to p11. Once 90% confluence was reached, cells were counted by an automated cell counter. Dots in line graphs represent the mean ± SEM values. ( d – i ) Representative histograms of the expression of CD44, CD29, CD90.2, Sca-1, CD45 and CD31 surface markers analyzed by FACS.

Article Snippet: CD29-APC, CD44-PE, CD45-FITC, CD31-APC, CD90.2-PE and Sca-1-APC antibodies were provided by Miltenyi Biotec (Auburn, CA, USA).

Techniques: Microscopy, Isolation, Cell Culture, Selection, Expressing

Mice were challenged with LPS via inhalation and sacrificed 4 hours later. In addition, neutrophils were depleted by antibody injection or mice were treated with simvastatin (2 µg/g bodyweight) 12 hours and one hour before or one hour after LPS exposure as indicated. A: Quantification of alveolar (top), interstitial (middle), and intravascular neutrophils (bottom) in mice treated as indicated. B: FITC-dextran clearance (top), albumin concentration (middle), and elastase activity (bottom) in BAL fluids in mice treated as indicated (n = 8–10 for each bar). Statistical significance was tested using one way ANOVA with Newman-Keuls Multiple Comparison test. * indicates significant difference compared to LPS-treated animals.

Journal: PLoS ONE

Article Title: Simvastatin Reduces Endotoxin-Induced Acute Lung Injury by Decreasing Neutrophil Recruitment and Radical Formation

doi: 10.1371/journal.pone.0038917

Figure Lengend Snippet: Mice were challenged with LPS via inhalation and sacrificed 4 hours later. In addition, neutrophils were depleted by antibody injection or mice were treated with simvastatin (2 µg/g bodyweight) 12 hours and one hour before or one hour after LPS exposure as indicated. A: Quantification of alveolar (top), interstitial (middle), and intravascular neutrophils (bottom) in mice treated as indicated. B: FITC-dextran clearance (top), albumin concentration (middle), and elastase activity (bottom) in BAL fluids in mice treated as indicated (n = 8–10 for each bar). Statistical significance was tested using one way ANOVA with Newman-Keuls Multiple Comparison test. * indicates significant difference compared to LPS-treated animals.

Article Snippet: Cell pellets were labeled with PerCP-Cy5.5 anti-mouse Ly-6G, PE anti-mouse CD115, APC-Cy7 anti-mouse CD45 und APC anti-Mouse Ly- 6G (all eBioscience) and FITC anti-mouse CD29 (Miltenyi Biotec).

Techniques: Injection, Concentration Assay, Activity Assay, Comparison

Isolated human neutrophils were pre-treated with Simvastatin (3 hours, 1 or 10 µM) and then activated with fMLP. MFI of surface expression of CD11b (A), CD29 (B) and FPRL1 (C) as measured by flow cytometry after staining with directly conjugated antibodies (n = 3–6; repetition = 4). D+E In vivo degranulation after LPS inhalation. Mice were challenged with LPS via inhalation and sacrificed 4 hours later. After isolation of neutrophils from the blood and the lung, MFI of surface expression of CD11b and CD29 as measured by flow cytometry after staining with directly conjugated antibodies (n = 4–6). Statistical significance was tested using one way ANOVA with Newman-Keuls Multiple Comparison test. * indicates significant difference in comparison to the fMLP or the LPS group.

Journal: PLoS ONE

Article Title: Simvastatin Reduces Endotoxin-Induced Acute Lung Injury by Decreasing Neutrophil Recruitment and Radical Formation

doi: 10.1371/journal.pone.0038917

Figure Lengend Snippet: Isolated human neutrophils were pre-treated with Simvastatin (3 hours, 1 or 10 µM) and then activated with fMLP. MFI of surface expression of CD11b (A), CD29 (B) and FPRL1 (C) as measured by flow cytometry after staining with directly conjugated antibodies (n = 3–6; repetition = 4). D+E In vivo degranulation after LPS inhalation. Mice were challenged with LPS via inhalation and sacrificed 4 hours later. After isolation of neutrophils from the blood and the lung, MFI of surface expression of CD11b and CD29 as measured by flow cytometry after staining with directly conjugated antibodies (n = 4–6). Statistical significance was tested using one way ANOVA with Newman-Keuls Multiple Comparison test. * indicates significant difference in comparison to the fMLP or the LPS group.

Article Snippet: Cell pellets were labeled with PerCP-Cy5.5 anti-mouse Ly-6G, PE anti-mouse CD115, APC-Cy7 anti-mouse CD45 und APC anti-Mouse Ly- 6G (all eBioscience) and FITC anti-mouse CD29 (Miltenyi Biotec).

Techniques: Isolation, Expressing, Flow Cytometry, Staining, In Vivo, Comparison

Flow cytometry antibody panel used for characterization.

Journal: Biomedical Reports

Article Title: Comparative study of biological characteristics of mesenchymal stem cells isolated from mouse bone marrow and peripheral blood

doi: 10.3892/br.2019.1236

Figure Lengend Snippet: Flow cytometry antibody panel used for characterization.

Article Snippet: Supplier CD29 PE HMs1-1 130-102-994 Miltenyi Biotec, Inc. CD44 FITC IM7.8.1 130-102-511 Miltenyi Biotec, Inc. CD105 PE MJ7/18 130-102-548 Miltenyi Biotec, Inc. CD90.2 FITC 30-H12 130-120-091 Miltenyi Biotec, Inc. CD146 FITC ME-9F1 130-102-230 Miltenyi Biotec, Inc. SCa-1 PE D7 130-102-832 Miltenyi Biotec, Inc. CD45 FITC 30F11.1 130-110-658 Miltenyi Biotec, Inc. CD140b PE APB5 130-118-457 Miltenyi Biotec, Inc. Open in a separate window CD, cluster of differentiation; PE, phycoethrin; FITC, fluorescein isothiocyanate.

Techniques: Flow Cytometry

Flow cytometric analysis of BM-MSCs and PB-MSCs. BM-MSCs were positive CD29 and negative for other markers, while PB-MSCs were positive for CD146, CD29, and CD140b and negative for Sca-1, CD44, CD45, CD90 and CD105. CD, cluster of differentiation; BM-MSCs, bone marrow-mesenchymal stromal cells; PB, peripheral blood; FITC, fluorescein isothiocyanate; PE, phycoerythrin.

Journal: Biomedical Reports

Article Title: Comparative study of biological characteristics of mesenchymal stem cells isolated from mouse bone marrow and peripheral blood

doi: 10.3892/br.2019.1236

Figure Lengend Snippet: Flow cytometric analysis of BM-MSCs and PB-MSCs. BM-MSCs were positive CD29 and negative for other markers, while PB-MSCs were positive for CD146, CD29, and CD140b and negative for Sca-1, CD44, CD45, CD90 and CD105. CD, cluster of differentiation; BM-MSCs, bone marrow-mesenchymal stromal cells; PB, peripheral blood; FITC, fluorescein isothiocyanate; PE, phycoerythrin.

Article Snippet: Supplier CD29 PE HMs1-1 130-102-994 Miltenyi Biotec, Inc. CD44 FITC IM7.8.1 130-102-511 Miltenyi Biotec, Inc. CD105 PE MJ7/18 130-102-548 Miltenyi Biotec, Inc. CD90.2 FITC 30-H12 130-120-091 Miltenyi Biotec, Inc. CD146 FITC ME-9F1 130-102-230 Miltenyi Biotec, Inc. SCa-1 PE D7 130-102-832 Miltenyi Biotec, Inc. CD45 FITC 30F11.1 130-110-658 Miltenyi Biotec, Inc. CD140b PE APB5 130-118-457 Miltenyi Biotec, Inc. Open in a separate window CD, cluster of differentiation; PE, phycoethrin; FITC, fluorescein isothiocyanate.

Techniques:

(A) MSCs (Cyagen) used in this study expressed CD29, CD44, and Sca-1 while remaining negative for CD31 and CD45 in at least two late passage numbers.

Journal: bioRxiv

Article Title: Evaluation of M2-like macrophage enrichment after diffuse traumatic brain injury through transient interleukin-4 expression from engineered mesenchymal stromal cells

doi: 10.1101/2020.01.28.918441

Figure Lengend Snippet: (A) MSCs (Cyagen) used in this study expressed CD29, CD44, and Sca-1 while remaining negative for CD31 and CD45 in at least two late passage numbers.

Article Snippet: For MSC cell-surface characterization, the following antibodies were used: APC-Vio770 CD29 (Miltenyi Biotec; clone: HMβ1-1), VioBright FITC CD44 (Miltenyi Biotec, US; clone: REA665), PerCP Sca-1 (Biolegend, US; clone: D7), PE CD31 (Miltenyi Biotec, US; clone: 390), PE CD45 (Biolegend, US; clone: 30-F11), and PE-Vio770 CD105 (Miltenyi Biotec, US; clone: MJ7/19).

Techniques:

Comparison of MAPK expression of bone marrow by abatacept.

Journal: Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders

Article Title: Analysis of Mitogen-Activated Protein Kinases in Bone and Cartilage of Patients with Rheumatoid Arthritis Treated with Abatacept

doi: 10.4137/CMAMD.S34424

Figure Lengend Snippet: Comparison of MAPK expression of bone marrow by abatacept.

Article Snippet: The experimental primary antibodies were described earlier, such as anti-TNF-α mouse monoclonal antibody (1:1,000 dilution; Biogenesis), antihuman IL-6 rabbit polyclonal antibody (1:500, Rockland), antihuman CD4, anti-human CD68 mouse monoclonal antibody (1:1,000; DAKO), antihuman OPN mouse monoclonal antibody (1:250; Novo-castra), antihuman OPG, rabbit polyclonal antibody (1:200; Santa Cruz Biotechnology), antihuman RANKL (FL-317) rabbit polyclonal antibody (1:200; Santa Cruz Biotechnology), antihuman CD29 (beta-1 integrin) mouse monoclonal antibody (1:350; Novocastra), antihuman phospho-p38 MAPK (Tyr180/Tyr182) mouse monoclonal antibody (1:500; Cell Signaling), antihuman phospho-p44/42 MAPK (Tyr202/Tyr204, ERK1/ERK2) mouse monoclonal antibody (1:500; Cell Signaling), and antihuman phosphor-JNK (1:500; Santa Cruz Biotechnology).

Techniques: Expressing

Comparison of MAPK expression of cartilage by abatacept.

Journal: Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders

Article Title: Analysis of Mitogen-Activated Protein Kinases in Bone and Cartilage of Patients with Rheumatoid Arthritis Treated with Abatacept

doi: 10.4137/CMAMD.S34424

Figure Lengend Snippet: Comparison of MAPK expression of cartilage by abatacept.

Article Snippet: The experimental primary antibodies were described earlier, such as anti-TNF-α mouse monoclonal antibody (1:1,000 dilution; Biogenesis), antihuman IL-6 rabbit polyclonal antibody (1:500, Rockland), antihuman CD4, anti-human CD68 mouse monoclonal antibody (1:1,000; DAKO), antihuman OPN mouse monoclonal antibody (1:250; Novo-castra), antihuman OPG, rabbit polyclonal antibody (1:200; Santa Cruz Biotechnology), antihuman RANKL (FL-317) rabbit polyclonal antibody (1:200; Santa Cruz Biotechnology), antihuman CD29 (beta-1 integrin) mouse monoclonal antibody (1:350; Novocastra), antihuman phospho-p38 MAPK (Tyr180/Tyr182) mouse monoclonal antibody (1:500; Cell Signaling), antihuman phospho-p44/42 MAPK (Tyr202/Tyr204, ERK1/ERK2) mouse monoclonal antibody (1:500; Cell Signaling), and antihuman phosphor-JNK (1:500; Santa Cruz Biotechnology).

Techniques: Expressing

Immunohistochemical comparison of the expression of MAPK in bone (magnification, 200×; black arrow shows strong positive). ( A ) and ( B ): CD29 (β-1 integrin); ( C ) and ( D ): JNK; ( E ) and ( F ): ERK; ( G ) and ( H ): P38 MAPK. ( A ), ( C ), ( E ), and ( G ): control group (MTX); ( B ), ( D ), ( F ), and ( H ): abatacept group.

Journal: Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders

Article Title: Analysis of Mitogen-Activated Protein Kinases in Bone and Cartilage of Patients with Rheumatoid Arthritis Treated with Abatacept

doi: 10.4137/CMAMD.S34424

Figure Lengend Snippet: Immunohistochemical comparison of the expression of MAPK in bone (magnification, 200×; black arrow shows strong positive). ( A ) and ( B ): CD29 (β-1 integrin); ( C ) and ( D ): JNK; ( E ) and ( F ): ERK; ( G ) and ( H ): P38 MAPK. ( A ), ( C ), ( E ), and ( G ): control group (MTX); ( B ), ( D ), ( F ), and ( H ): abatacept group.

Article Snippet: The experimental primary antibodies were described earlier, such as anti-TNF-α mouse monoclonal antibody (1:1,000 dilution; Biogenesis), antihuman IL-6 rabbit polyclonal antibody (1:500, Rockland), antihuman CD4, anti-human CD68 mouse monoclonal antibody (1:1,000; DAKO), antihuman OPN mouse monoclonal antibody (1:250; Novo-castra), antihuman OPG, rabbit polyclonal antibody (1:200; Santa Cruz Biotechnology), antihuman RANKL (FL-317) rabbit polyclonal antibody (1:200; Santa Cruz Biotechnology), antihuman CD29 (beta-1 integrin) mouse monoclonal antibody (1:350; Novocastra), antihuman phospho-p38 MAPK (Tyr180/Tyr182) mouse monoclonal antibody (1:500; Cell Signaling), antihuman phospho-p44/42 MAPK (Tyr202/Tyr204, ERK1/ERK2) mouse monoclonal antibody (1:500; Cell Signaling), and antihuman phosphor-JNK (1:500; Santa Cruz Biotechnology).

Techniques: Immunohistochemical staining, Expressing

Immunohistochemical comparison of the expression of MAPK in cartilage (magnification, 200×; black arrow shows strong positive). ( A ) and ( B ): CD29 (β-1 integrin); ( C ) and ( D ): JNK; ( E ) and ( F ): ERK; ( G ) and ( H ): P38 MAPK. ( A ), ( C ), ( E ), and ( G ): control group (MTX); ( B ), ( D ), ( F ), and ( H ): abatacept group.

Journal: Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders

Article Title: Analysis of Mitogen-Activated Protein Kinases in Bone and Cartilage of Patients with Rheumatoid Arthritis Treated with Abatacept

doi: 10.4137/CMAMD.S34424

Figure Lengend Snippet: Immunohistochemical comparison of the expression of MAPK in cartilage (magnification, 200×; black arrow shows strong positive). ( A ) and ( B ): CD29 (β-1 integrin); ( C ) and ( D ): JNK; ( E ) and ( F ): ERK; ( G ) and ( H ): P38 MAPK. ( A ), ( C ), ( E ), and ( G ): control group (MTX); ( B ), ( D ), ( F ), and ( H ): abatacept group.

Article Snippet: The experimental primary antibodies were described earlier, such as anti-TNF-α mouse monoclonal antibody (1:1,000 dilution; Biogenesis), antihuman IL-6 rabbit polyclonal antibody (1:500, Rockland), antihuman CD4, anti-human CD68 mouse monoclonal antibody (1:1,000; DAKO), antihuman OPN mouse monoclonal antibody (1:250; Novo-castra), antihuman OPG, rabbit polyclonal antibody (1:200; Santa Cruz Biotechnology), antihuman RANKL (FL-317) rabbit polyclonal antibody (1:200; Santa Cruz Biotechnology), antihuman CD29 (beta-1 integrin) mouse monoclonal antibody (1:350; Novocastra), antihuman phospho-p38 MAPK (Tyr180/Tyr182) mouse monoclonal antibody (1:500; Cell Signaling), antihuman phospho-p44/42 MAPK (Tyr202/Tyr204, ERK1/ERK2) mouse monoclonal antibody (1:500; Cell Signaling), and antihuman phosphor-JNK (1:500; Santa Cruz Biotechnology).

Techniques: Immunohistochemical staining, Expressing